FR2241307B1 - - Google Patents

Info

Publication number
FR2241307B1
FR2241307B1 FR7429137A FR7429137A FR2241307B1 FR 2241307 B1 FR2241307 B1 FR 2241307B1 FR 7429137 A FR7429137 A FR 7429137A FR 7429137 A FR7429137 A FR 7429137A FR 2241307 B1 FR2241307 B1 FR 2241307B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7429137A
Other languages
French (fr)
Other versions
FR2241307A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of FR2241307A1 publication Critical patent/FR2241307A1/fr
Application granted granted Critical
Publication of FR2241307B1 publication Critical patent/FR2241307B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0825Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
FR7429137A 1973-08-25 1974-08-26 Antidepressant peptide cpds. - contg. pyroglutamyl as the N-terminal amino-acid Granted FR2241307A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732343037 DE2343037A1 (de) 1973-08-25 1973-08-25 Arzneimittel mit antidepressiver wirkung

Publications (2)

Publication Number Publication Date
FR2241307A1 FR2241307A1 (en) 1975-03-21
FR2241307B1 true FR2241307B1 (US20100012521A1-20100121-C00001.png) 1978-07-21

Family

ID=5890743

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7429137A Granted FR2241307A1 (en) 1973-08-25 1974-08-26 Antidepressant peptide cpds. - contg. pyroglutamyl as the N-terminal amino-acid

Country Status (8)

Country Link
AU (1) AU7259274A (US20100012521A1-20100121-C00001.png)
BE (1) BE819200A (US20100012521A1-20100121-C00001.png)
DE (1) DE2343037A1 (US20100012521A1-20100121-C00001.png)
DK (1) DK452374A (US20100012521A1-20100121-C00001.png)
FR (1) FR2241307A1 (US20100012521A1-20100121-C00001.png)
LU (1) LU70784A1 (US20100012521A1-20100121-C00001.png)
NL (1) NL7411104A (US20100012521A1-20100121-C00001.png)
ZA (1) ZA745423B (US20100012521A1-20100121-C00001.png)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4125578A (en) * 1977-11-09 1979-05-17 Merck & Co Inc Tripeptides
HU180926B (en) * 1979-06-28 1983-05-30 Richter Gedeon Vegyeszet Process for preparing trh analogues,tripeptide amides infectives on the central nerve sysrhem
HU184481B (en) * 1981-10-02 1984-08-28 Richter Gedeon Vegyeszet Process for producing tripeptides for diminishing appetite
IT1186733B (it) * 1985-06-05 1987-12-16 Eniricerche Spa Composti tripeptidici ad azione ipotensiva
US6221367B1 (en) 1992-06-15 2001-04-24 Emisphere Technologies, Inc. Active agent transport systems
US6099856A (en) 1992-06-15 2000-08-08 Emisphere Technologies, Inc. Active agent transport systems
US5629020A (en) 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US5578323A (en) 1992-06-15 1996-11-26 Emisphere Technologies, Inc. Proteinoid carriers and methods for preparation and use thereof
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US5811127A (en) 1992-06-15 1998-09-22 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US5401516A (en) 1992-12-21 1995-03-28 Emisphere Technologies, Inc. Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
EP1025840B1 (en) 1993-04-22 2005-06-29 Emisphere Technologies, Inc. Oral drug compositions
US5643957A (en) 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5866536A (en) 1995-03-31 1999-02-02 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6001347A (en) 1995-03-31 1999-12-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
CN1151836C (zh) 1995-03-31 2004-06-02 艾米斯菲尔技术有限公司 用作传送活性剂的化合物和组合物
US6051258A (en) 1995-06-07 2000-04-18 Emisphere Technologies, Inc. Proteinoid emulsions and methods for preparation and use thereof
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
US5824345A (en) 1995-06-07 1998-10-20 Emisphere Technologies, Inc. Fragrances and flavorants
WO1997010197A1 (en) 1995-09-11 1997-03-20 Emisphere Technologies, Inc. METHOD FOR PREPARING φ-AMINOALKANOIC ACID DERIVATIVES FROM CYCLOALKANONES
EP0904065A4 (en) 1996-06-14 2000-06-14 Emisphere Tech Inc MICRO-ENCLOSED FRAGRANCES AND PRODUCTION METHOD
US5939381A (en) 1997-02-07 1999-08-17 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6051561A (en) * 1997-02-07 2000-04-18 Emisphere Technologies Inc. Compounds and compositions for delivering active agents
US5776888A (en) * 1997-02-07 1998-07-07 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5879681A (en) 1997-02-07 1999-03-09 Emisphere Technolgies Inc. Compounds and compositions for delivering active agents
US5773647A (en) * 1997-02-07 1998-06-30 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6313088B1 (en) 1997-02-07 2001-11-06 Emisphere Technologies, Inc. 8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5804688A (en) 1997-02-07 1998-09-08 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6060513A (en) 1997-02-07 2000-05-09 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5990166A (en) 1997-02-07 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5863944A (en) 1997-04-30 1999-01-26 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5962710A (en) 1997-05-09 1999-10-05 Emisphere Technologies, Inc. Method of preparing salicyloylamino acids
WO2006133353A2 (en) 2005-06-08 2006-12-14 The University Of North Carolina At Chapel Hill Methods of facilitating neural cell survival using non-peptide and peptide bdnf neurotrophin mimetics
CN105189449A (zh) 2013-03-15 2015-12-23 特罗菲克斯制药股份有限公司 非肽bdnf神经营养蛋白模拟物
RU2015141934A (ru) 2013-03-15 2017-04-20 Фарматрофикс, Инк. Непептидные миметики нейротрофина bdnf

Also Published As

Publication number Publication date
AU7259274A (en) 1976-02-26
BE819200A (fr) 1975-02-26
DK452374A (US20100012521A1-20100121-C00001.png) 1975-04-28
NL7411104A (nl) 1975-02-27
FR2241307A1 (en) 1975-03-21
DE2343037A1 (de) 1975-03-06
ZA745423B (en) 1975-08-27
LU70784A1 (US20100012521A1-20100121-C00001.png) 1976-08-19

Similar Documents

Publication Publication Date Title
AR201758A1 (US20100012521A1-20100121-C00001.png)
AU476761B2 (US20100012521A1-20100121-C00001.png)
AU465372B2 (US20100012521A1-20100121-C00001.png)
AR201235Q (US20100012521A1-20100121-C00001.png)
AR201231Q (US20100012521A1-20100121-C00001.png)
AU474593B2 (US20100012521A1-20100121-C00001.png)
AU474511B2 (US20100012521A1-20100121-C00001.png)
AU474838B2 (US20100012521A1-20100121-C00001.png)
AU465453B2 (US20100012521A1-20100121-C00001.png)
AU465434B2 (US20100012521A1-20100121-C00001.png)
AU471343B2 (US20100012521A1-20100121-C00001.png)
AU450229B2 (US20100012521A1-20100121-C00001.png)
AU476714B2 (US20100012521A1-20100121-C00001.png)
AR201229Q (US20100012521A1-20100121-C00001.png)
AU466283B2 (US20100012521A1-20100121-C00001.png)
AU476696B2 (US20100012521A1-20100121-C00001.png)
AU472848B2 (US20100012521A1-20100121-C00001.png)
AR199451A1 (US20100012521A1-20100121-C00001.png)
AU477823B2 (US20100012521A1-20100121-C00001.png)
AU461342B2 (US20100012521A1-20100121-C00001.png)
AU471461B2 (US20100012521A1-20100121-C00001.png)
AR200256A1 (US20100012521A1-20100121-C00001.png)
AU476873B1 (US20100012521A1-20100121-C00001.png)
AR210729A1 (US20100012521A1-20100121-C00001.png)
AU477824B2 (US20100012521A1-20100121-C00001.png)

Legal Events

Date Code Title Description
ST Notification of lapse